SEC Form 4 · accession 0001209191-15-082187
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John J Kody
Officer — EVP, Chief Commercial Officer
Period of report
Nov 24, 2015
Accepted (ET)
Nov 25, 2015 · 1:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Nov 24, 2015 | M | 18,975 | — | A | 18,975 | D | |
| Ordinary Shares | Nov 24, 2015 | F | 6,209 | $21.68 | D | 12,766 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Nov 24, 2015 | M | 18,975 | D | — | — | Ordinary Shares | 18,975 | 56,925 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On November 24, 2014, the reporting person was granted 75,900 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.